MarketCap
Facebook
X
TelegramQuarterly report 2022-Q2
added 08-09-2022
Country |
 Germany |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
62.9 M |
Market Cap[1] |
$ 622 M |
EBITDA (LTM) |
$ -43 M |
P/E (LTM) |
-8.57 |
P/S (LTM) |
- |
EPS (LTM) |
-1.06 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Apellis Pharmaceuticals
APLS
|
$ 20.15 | -2.68 % | $ 2.54 B | Nasdaq Global Select Market,SPB |  USA |
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market | Germany |
 |
Aptorum Group Limited
APM
|
$ 0.82 | -3.48 % | $ 4.47 M | Nasdaq Global Select Market |  China |
 |
Axsome Therapeutics
AXSM
|
$ 163.7 | -1.61 % | $ 8.14 B | Nasdaq Global Market,SPB | USA |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
AbCellera Biologics
ABCL
|
$ 3.72 | -2.75 % | $ 1.11 B | Nasdaq Global Select Market |  Canada |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
Burford Capital Limited
BUR
|
$ 8.52 | -2.46 % | $ 1.39 B | NYSE | Britain |
 |
Corvus Pharmaceuticals
CRVS
|
$ 17.75 | -0.79 % | $ 852 M | Nasdaq Global Market | USA |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Certara
CERT
|
$ 7.16 | 1.49 % | $ 1.15 B | Nasdaq Global Select Market | USA |
 |
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | USA |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Capricor Therapeutics
CAPR
|
$ 25.91 | -3.56 % | $ 694 M | Nasdaq Capital Market | USA |
 |
Acasti Pharma
ACST
|
- | 4.01 % | $ 150 M | Nasdaq Capital Market | Canada |
 |
Codexis
CDXS
|
$ 0.99 | -3.28 % | $ 72.7 M | Nasdaq Global Select Market | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
$ 24.0 | 0.5 % | $ 2.93 B | Nasdaq Capital Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | Canada |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Agenus
AGEN
|
$ 3.19 | -4.64 % | $ 1.14 M | Nasdaq Capital Market | USA |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market |  Israel |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Agios Pharmaceuticals
AGIO
|
$ 28.78 | -1.44 % | $ 1.67 B | Nasdaq Global Select Market,SPB | USA |
|
Champions Oncology
CSBR
|
$ 6.0 | -1.15 % | $ 82 M | Nasdaq Capital Market | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Завод ДИОД
DIOD
|
- | - | - | MOEX,SPB | Russia |
 |
Фармсинтез
LIFE
|
- | - | - | MOEX | Russia |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
Cellectis S.A.
CLLS
|
$ 3.67 | -3.42 % | $ 116 M | Nasdaq Global Market | France |
 |
Alector
ALEC
|
$ 2.11 | -4.75 % | $ 217 M | Nasdaq Global Select Market,SPB | USA |
 |
KalVista Pharmaceuticals
KALV
|
$ 15.68 | -2.4 % | $ 779 M | Nasdaq Global Select Market | Britain |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
Aileron Therapeutics
ALRN
|
- | 10.36 % | $ 9.8 M | Nasdaq Global Select Market | USA |
 |
Altimmune
ALT
|
$ 4.17 | 0.24 % | $ 296 M | Nasdaq Global Market | USA |
 |
Teligent, Inc.
TLGT
|
- | -13.85 % | $ 16.1 M | Nasdaq Global Select Market | USA |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Viela Bio, Inc.
VIE
|
- | - | $ 2.91 B | Nasdaq Global Select Market | USA |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
Amarin Corporation plc
AMRN
|
$ 14.27 | 2.44 % | $ 5.92 B | Nasdaq Global Market |  Irlanda |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.